Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Genome Copying Errors

Genome Copying Errors

DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their survival. Therefore, the copying errors are checked and repaired at three levels.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring the prognostic implications of programmed death-ligand 1 expression in canine nodal lymphoma: Insights from surface membrane expression, transcript amount and plasmatic levels.

Research in veterinary science·2026

Same author

BTK Degraders in Lymphoid Malignancies: New Modality, New Resistance Rules?

Blood cancer discovery·2026

Same author

A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial.

Cancers·2026

Same author

Antimicrobial Peptides Induce Cell Death in Marginal Zone Lymphoma Models Resistant to Targeted Therapies.

EJHaem·2026

Same author

Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis.

Nature immunology·2026

Same author

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Blood·2026

Same journal

Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report.

Frontiers in oncology·2026

Same journal

Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression.

Frontiers in oncology·2026

Same journal

Expert consensus from the Chinese medical association on pharmaceutical management of combined cardio-oncology physician-pharmacist clinics.

Frontiers in oncology·2026

Same journal

Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma.

Frontiers in oncology·2026

Same journal

The aMAP score improves discrimination of prognostic models in hepatocellular carcinoma after radiofrequency ablation.

Frontiers in oncology·2026

Same journal

Cuproptosis and prostate cancer: from molecular mechanisms and microenvironment remodeling to precision therapy.

Frontiers in oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 25, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas.

Luciano Cascione^1,2, Luca Aresu³, Michael Baudis^2,4

¹Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.

Frontiers in Oncology

|December 21, 2020

Summary

This summary is machine-generated.

Copy number variations (CNVs) are key in cancer's genetic makeup. This review details CNVs in diffuse large B cell lymphoma (DLBCL), aiding in target discovery and disease classification.

Keywords:

CDKN2A MYC TP53 copy number aberrations diffuse large B cell lymphoma genetic alteration hematological malignancies lymphoma

More Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Detection of Copy Number Alterations Using Single Cell Sequencing

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

Related Experiment Videos

Last Updated: Nov 25, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Detection of Copy Number Alterations Using Single Cell Sequencing

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

Area of Science:

Oncology
Genetics
Hematology

Background:

Copy number aberrations (CNVs) are significant drivers of cancer development and progression.
Diffuse large B cell lymphoma (DLBCL) is a common B-cell malignancy with variable outcomes.
DLBCL is a heterogeneous disease, necessitating refined classification and understanding.

Purpose of the Study:

To review the types and frequencies of regional DNA CNVs in DLBCL.
To examine CNV patterns in specific DLBCL contexts: de novo DLBCL, transformation from indolent lymphomas, and DLBCL in immunodeficient individuals.

Main Methods:

Systematic review of existing literature on CNVs in DLBCL.
Analysis of CNV data from various DLBCL subtypes and patient cohorts.

Main Results:

CNVs play a crucial role in the genetic landscape of DLBCL.
Specific CNV profiles are associated with different DLBCL subtypes and clinical outcomes.
Understanding CNVs can improve DLBCL sub-classification and identify potential therapeutic targets.

Conclusions:

CNVs are important biomarkers and potential therapeutic targets in DLBCL.
Further research into CNVs can lead to more personalized treatment strategies for DLBCL patients.